Alto Neuroscience Inc — Cash Flow (NYSE:ANRO) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Nachrichten

Alto Neuroscience schließt Patientenrekrutierung für Schizophrenie-Studie ab

Alto Neuroscience completes enrollment in schizophrenia drug trial

Alto Neuroscience erhält US-Patent für Methode zur Depressionsbehandlung

Alto Neuroscience receives patent for depression treatment method

Chardan Capital Markets assumes coverage on Alto Neuroscience stock with Buy rating

Tesla and ServiceNow among market cap stock movers on Monday

Alto Neuroscience: 4 Shots At Success In CNS Diseases In 2026 (NYSE:ANRO)

Google, Alibaba among market cap stock movers on Monday

Jazz Pharmaceuticals, Sigma Lithium, Zymeworks And Other Big Stocks Moving Higher On Monday - Alto Neuroscience (NYSE:ANRO), Albemarle (NYSE:ALB)

BTIG startet Coverage für Alto Neuroscience mit "Kaufen" – Präzisionspsychiatrie im Fokus

Alto Neuroscience stock initiated at Buy by BTIG on precision psychiatry approach

This Alto Neuroscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Adverum Biotechnologies (NASDAQ:ADVM), Alto Neuroscience (NYSE:ANRO)